Patents
Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
01/2010
01/14/2010WO2010006343A2 Glycopeptide constructs and uses thereof
01/14/2010US20100009425 Glycoprotein synthesis
01/14/2010CA2734348A1 Glycopeptide constructs and uses thereof
01/13/2010EP2142660A2 Methods and systems for o-glycosylating proteins
01/13/2010EP2142572A1 Tgfp-cap peptide and its uses
01/12/2010US7645857 Methods of indentifying modulators of the FGF receptor
12/2009
12/30/2009WO2009054967A3 Compositions for delivery of glycopeptide antibiotics
12/30/2009CN101613396A Amorphous vancomycin hydrochloride as well as preparation method, application and pharmaceutical composition thereof
12/29/2009US7638495 inhibiting precipitation; bone morphogenic proteins
12/24/2009US20090317906 Gene silencing using sense dna and antisense rna hybrid constructs coupled to peptides facilitating the uptake into cells
12/24/2009US20090317480 Chimeric immunomodulatory compounds and methods of using the same-ii
12/24/2009US20090317381 Clearance of abnormal iga1 in iga1 deposition diseases
12/23/2009WO2009120022A3 Immunopeptide, and a composition for the prophylaxis or treatment of hpv-related medical conditions comprising the same
12/23/2009CN101607986A Method for preparing boningmycin by chemical semisynthesis
12/22/2009US7635765 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin
12/22/2009US7635750 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation
12/22/2009CA2276267C Peptide-lipid conjugates, liposomes and liposomal drug delivery
12/17/2009US20090312521 Antibiotic drosocin derivatives
12/17/2009US20090312197 Peptide nucleic acids conjugated with multi-amine linkers and nucleic acid detecting device using the same
12/16/2009EP0996455B1 Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof
12/10/2009US20090305949 Glycosylated specificity exchanger
12/09/2009EP2130837A1 Novel nuclear translocation peptide
12/03/2009WO2008093165A3 The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
12/02/2009EP1633759B1 Cross-linked glycopeptide-cephalosporin antibiotics
11/2009
11/19/2009US20090286717 Glycopeptide Antibiotic Derivative
11/18/2009EP1575990B1 Solid phase bound PNA-dimers and their synthesis
11/12/2009US20090280560 Yeast cell surface display of proteins and uses thereof
11/10/2009US7615244 Glycopeptide and peptide having a kokumi taste imparting function, and method of imparting the kokumi taste to foods
11/05/2009US20090275739 Purification of Glycopeptides
11/03/2009US7612037 Vancomycin coupled through an oxime to and aminochlorothiazolo pyridinium substituted bicyclic hetero ring; antibiotics
11/03/2009US7611711 VEGFR-3 inhibitor materials and methods
10/2009
10/29/2009US20090269734 Method for determination of recognition specificity of virus for receptor sugar chain
10/28/2009CN100554279C Synthetic polysaccharide antigens for immunological intervention in disease
10/27/2009US7608602 Beta -1-(4-Allyloxycarbonylamino-2-oxo-1H-pyrimidin-1-yl)-2-deoxy-2,2-difluororibose, for example; for treating or preventing diseases or disorders such as cancer or viral infections
10/27/2009US7608591 Targeted delivery to legumain-expressing cells
10/27/2009CA2146145C Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
10/22/2009US20090263858 Process for synthesis of mucin-type peptides and muc1-related glycopeptides
10/20/2009US7605133 Isolated peptides to treat alpha-synuclein diseases
10/20/2009US7605125 Anticancer agents
10/15/2009WO2009102859A3 Polypeptides for microbial detection
10/15/2009US20090258820 Echinocandin/carbohydrate complexes
10/14/2009EP1558747B1 Glycoprotein synthesis
10/14/2009CN100549026C Vacomycin column chromatography purifying method
10/13/2009US7601690 Cross-linked glycopeptide-cephalosporin antibiotics
10/08/2009US20090253895 Printable Materials
10/01/2009WO2009120022A2 Immunopeptide, and a composition for the prophylaxis or treatment of hpv-related medical conditions comprising the same
10/01/2009US20090247732 Synthesis of glycopeptides with superior pharmacokinetic properties
09/2009
09/24/2009WO2009115782A2 Compound
09/17/2009US20090234095 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
09/16/2009EP1343814B1 Immunogenic glycopeptides, screening, preparation and uses
09/15/2009CA2149925C Peptidic derivates of .alpha.-msh and their uses
09/10/2009US20090227544 Bone Targeted Therapeutics and Methods of Making and Using the Same
09/10/2009US20090227488 Class of bioactive glycoprotein
09/09/2009EP2097440A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
09/03/2009WO2009108807A1 Glycopeptides and methods of making and using them
09/03/2009US20090221471 Prodrugs of vancomycin with hydrolysis resistant polymer linkages
09/03/2009CA2716622A1 Glycopeptides and methods of making and using them
09/02/2009CN101519439A Freezeproof polypeptide, synthesis, composition containing same and application thereof
08/2009
08/27/2009US20090215982 Glycopeptide derivatives and pharmaceutical compositions containing the same
08/27/2009US20090215673 a solution of the glycopeptide derivatives containing phosphono group which acts as antibacterial agent, a polystyrene modified with divinylbenzene bead and an acidified aqueous solution ( acetic acid or HCl) of polar solvent e.g. methanol, acetonitrile, ethanol; for purification by resin chromatography
08/27/2009US20090215172 Methods and Compositions Related to Cyclic Peptide Synthesis
08/27/2009US20090214598 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
08/26/2009CN100532392C Reductive alkylation process
08/20/2009US20090209452 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
08/19/2009EP1735337B1 Method of producing highly pure teicoplanin
08/18/2009US7576071 Antithrombotic compound
08/07/2009CA2653153A1 Antifreeze glycoprotein analogues and uses thereof
08/05/2009CN101501064A Glycopeptide antibiotic derivative
08/05/2009CN100522995C Cell wall acyl-alanyl-D-isoglutamine derivative and its preparation, medicine composition and use
07/2009
07/23/2009US20090186802 Cell Penetrating Peptide Conjugates for Delivering of Nucleic Acids into a Cell
07/22/2009EP2080525A1 Remodeling and Glycoconjugation of Peptides
07/22/2009CN101486755A House lizard, preparation and medical use
07/16/2009WO2009088949A1 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
07/16/2009CA2710683A1 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
07/14/2009US7560535 Pharmacokinetics; glycosyltransferases; antibodies; immunoglobulins
07/02/2009WO2009081958A1 Glycosylated glycopeptide antibiotic derivative
07/02/2009US20090169509 O-linked glycosylation of peptides
07/02/2009CA2710417A1 Glycosylated glycopeptide antibiotic derivatives
07/01/2009EP1713439B1 Pharmaceutical preparation for the oral cavity
07/01/2009CN100506073C Material and method for producing food
06/2009
06/30/2009US7553962 Cross-linked glycopeptide-cephalosporin antibiotics
06/30/2009CA2095521C Hepatitis c virus asialoglycoproteins
06/25/2009US20090163844 Methods for the treatment or prevention of scars and/or keloids
06/24/2009CN101463076A Method for refining bleocin
06/23/2009US7550428 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water
06/23/2009US7550146 Mucin motif found on epithelial tumor cell surfaces; antibody induction; cancer treatment
06/17/2009EP2069388A2 Peptides derived from the c2 domain of epsilon pkc, and use thereof
06/17/2009CN101456903A Separation and purification method of vancocin
06/09/2009US7544364 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction
05/2009
05/28/2009US20090137763 Glucosamine nucleotide sugars
05/28/2009US20090137494 Tumor-activated prodrug compounds and treatment
05/28/2009US20090137460 Cross-linked glycopeptide-cephalosporin antibiotics
05/27/2009CN101440127A Preparation of high-purity vancomycin hydrochloride
05/27/2009CN100491395C Process for producing modified peptide
05/21/2009US20090131304 Semi-Synthetic Desmethyl-Vancomycin-Based Glycopeptides With Antibiotic Activity
05/19/2009US7534435 Glycosylated specificity exchangers
05/14/2009WO2007054977A3 Method and composition for skin depigmentation
05/12/2009US7531623 Such as of telavancin isolated via precipitation, filtration; storage stability
05/12/2009US7531622 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells
05/12/2009US7531507 Such as 3-tert-Butyl-D-alanyl-3-(6-trifluoromethylpyridin-3-yl)-L-alanyl-de(1-D-leucyl-2-L-leucyl)-lysobactin bistrifluoroacetate; cell wall biosynthesis inhibitors; treatment and/or prophylaxis of bacterial infectious diseases
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 34